Related Experiment Videos
[Bioassay for endocrine disruptors by using yeast two-hybrid system]
1Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamada-oka, Suita, Osaka 565-0871, Japan. nisihara@phs.osaka-u.ac.jp
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|October 2, 2001
Summary
A new yeast two-hybrid assay effectively screens for endocrine disruptors (EDs). This simple, inexpensive method identified 64 positive compounds, aiding chemical risk assessment.
Area of Science:
- Environmental Science
- Biochemistry
- Toxicology
Background:
- Identifying endocrine disruptors (EDs) is crucial for public health.
- Existing screening methods require improvement for efficiency and cost-effectiveness.
Purpose of the Study:
- To develop and validate a novel in vitro screening assay for detecting endocrine-disrupting chemicals (EDCs).
- To identify structural characteristics of compounds exhibiting estrogenic activity.
Main Methods:
- Utilized a yeast two-hybrid system to detect ligand-dependent protein interactions.
- Measured hormonal activity via beta-galactosidase reporter gene expression.
- Screened over 500 chemical compounds for estrogenic activity.
Main Results:
- The developed assay demonstrated high repeatability for detecting agonists and was applicable to antagonists and metabolites.
- Sixty-four out of 500+ tested chemicals showed positive estrogenic activity.
- A common structural feature of positive compounds was identified: a phenol with a para-positioned hydrophobic moiety and no ortho-positioned bulky groups.
Conclusions:
- The yeast two-hybrid assay is a simple, inexpensive, and reliable tool for primary screening of potential endocrine disruptors.
- The identified structural features can guide further risk assessment and the design of safer chemicals.
- This method has been adopted by over 40 laboratories in Japan, highlighting its utility and applicability.